Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Octapharma Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (38)
Australian Public Assessment Report (AusPAR) (2)
Prescription medicine registration (2)
Prescription medicine decision summary (1)

Date

2021 (9)
2020 (3)
2018 (7)
2016 (1)
2014 (5)
2009 (5)
2007 (3)
2006 (5)
2005 (1)
2004 (4)

Results for "[search-keyword]"

Search

Sponsor content

43 result(s) found, displaying 11 to 20

Cutaquig

12 May 2021

Prescription medicine decision summary

Australian prescription medicine decision summary
CUTAQUIG (Octapharma Australia Pty Ltd)

21 April 2021

Prescription medicine registration

Active ingredients: human immunoglobulin g.
PANZYGA human normal immunoglobulin 30g/300mL solution for intravenous infusion bottle (291644)

10 September 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PANZYGA human normal immunoglobulin 30g/300mL solution for intravenous infusion bottle.
PANZYGA human normal immunoglobulin 2.5g/25mL solution for intravenous infusion vial (291645)

10 September 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PANZYGA human normal immunoglobulin 2.5g/25mL solution for intravenous infusion vial.
PANZYGA human normal immunoglobulin 20g/200mL solution for intravenous infusion bottle (291646)

10 September 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PANZYGA human normal immunoglobulin 20g/200mL solution for intravenous infusion bottle.
PANZYGA human normal immunoglobulin 5g/50mL, solution for intravenous infusion bottle (291647)

10 September 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PANZYGA human normal immunoglobulin 5g/50mL, solution for intravenous infusion bottle.
PANZYGA human normal immunoglobulin 10g/100mL solution for intravenous infusion bottle (291648)

10 September 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PANZYGA human normal immunoglobulin 10g/100mL solution for intravenous infusion bottle.
PANZYGA human normal immunoglobulin 1g/10mL solution for intravenous infusion vial (291740)

10 September 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PANZYGA human normal immunoglobulin 1g/10mL solution for intravenous infusion vial.
PANZYGA (Octapharma Australia Pty Ltd)

5 September 2018

Prescription medicine registration

Active ingredients: human immunoglobulin G.
Nuwiq Human cell line recombinant human factor VIII (Human-cl rhFVIII), 500IU, powder and solvent for solution for injection (213939)

10 November 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Nuwiq Human cell line recombinant human factor VIII (Human-cl rhFVIII), 500IU, powder and solvent for solution for injection.

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.